lifemd inc - LFMD

LFMD

Close Chg Chg %
3.09 -0.10 -3.24%

Open Market

2.99

-0.10 (3.24%)

Volume: 422.60K

Last Updated:

Sep 9, 2026, 12:25 PM EDT

Company Overview: lifemd inc - LFMD

LFMD Key Data

Open

$3.07

Day Range

2.99 - 3.11

52 Week Range

2.56 - 7.32

Market Cap

$148.46M

Shares Outstanding

48.20M

Public Float

39.20M

Beta

2.04

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.52

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

700.11K

 

LFMD Performance

1 Week
 
0.32%
 
1 Month
 
-13.20%
 
3 Months
 
-34.26%
 
1 Year
 
-46.72%
 
5 Years
 
-56.96%
 

LFMD Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About lifemd inc - LFMD

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

LFMD At a Glance

LifeMD, Inc.
236 Fifth Avenue
New York, New York 10001-7606
Phone 1-866-351-5907 Revenue 194.06M
Industry Medical/Nursing Services Net Income -7,106,359.00
Sector Health Services Employees 389
Fiscal Year-end 12 / 2026
View SEC Filings

LFMD Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.793
Price to Book Ratio 6.871
Price to Cash Flow Ratio 18.59
Enterprise Value to EBITDA -341.683
Enterprise Value to Sales 0.636
Total Debt to Enterprise Value 0.051

LFMD Efficiency

Revenue/Employee 498,856.55
Income Per Employee -18,268.275
Receivables Turnover 20.854
Total Asset Turnover 2.717

LFMD Liquidity

Current Ratio 1.247
Quick Ratio 1.18
Cash Ratio 0.885

LFMD Profitability

Gross Margin 79.751
Operating Margin -3.952
Pretax Margin -5.249
Net Margin -3.662
Return on Assets -14.324
Return on Equity -115.808
Return on Total Capital -34.709
Return on Invested Capital -51.805

LFMD Capital Structure

Total Debt to Total Equity 27.309
Total Debt to Total Capital 21.451
Total Debt to Total Assets 8.981
Long-Term Debt to Equity 24.535
Long-Term Debt to Total Capital 19.272
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Lifemd Inc - LFMD

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
119.03M 152.55M 212.45M 194.06M
Sales Growth
+28.16% +28.15% +39.27% -8.66%
Cost of Goods Sold (COGS) incl D&A
23.70M 26.53M 34.29M 39.29M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.77M 6.60M 9.49M 7.31M
Depreciation
161.88K 203.95K 487.98K 865.52K
Amortization of Intangibles
3.61M 6.40M 9.00M 6.44M
COGS Growth
+13.76% +11.95% +29.22% +14.61%
Gross Income
95.33M 126.01M 178.17M 154.76M
Gross Income Growth
+32.33% +32.18% +41.39% -13.14%
Gross Profit Margin
+80.09% +82.61% +83.86% +79.75%
2022 2023 2024 2025 5-year trend
SG&A Expense
128.30M 134.21M 185.19M 151.36M
Research & Development
2.97M 6.06M 9.51M 7.35M
Other SG&A
125.33M 128.15M 175.68M 144.01M
SGA Growth
+4.40% +4.60% +37.99% -18.27%
Other Operating Expense
6.72M 6.30M 9.12M 11.07M
Unusual Expense
- 3.70M 325.20K 1.16M
EBIT after Unusual Expense
(43.38M) (14.81M) (16.14M) (8.83M)
Non Operating Income/Expense
- - - -
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.28M 2.60M 2.18M 1.36M
Interest Expense Growth
-57.75% +103.50% -15.97% -37.62%
Gross Interest Expense
1.28M 2.60M 2.18M 1.36M
Interest Capitalized
- - - -
-
Pretax Income
(44.66M) (17.41M) (18.33M) (10.19M)
Pretax Income Growth
+27.16% +61.01% -5.26% +44.42%
Pretax Margin
-37.52% -11.41% -8.63% -5.25%
Income Tax
360.70K 428.00K 402.00K 45.72K
Income Tax - Current - Domestic
6.70K 111.00K 340.00K 45.72K
Income Tax - Current - Foreign
- - 317.00K 62.00K
-
Income Tax - Deferred - Domestic
- - - 354.00K
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(45.02M) (17.84M) (18.73M) (10.23M)
Minority Interest Expense
- 514.63K 2.76M 153.23K
Net Income
(45.54M) (20.60M) (18.88M) (10.23M)
Net Income Growth
+25.23% +54.77% +8.32% +45.81%
Net Margin Growth
-38.25% -13.50% -8.89% -5.27%
Extraordinaries & Discontinued Operations
- - - 3.13M
-
Discontinued Operations
- - - 3.13M
-
Net Income After Extraordinaries
(45.54M) (20.60M) (18.88M) (7.11M)
Preferred Dividends
3.11M 3.11M 3.11M 3.11M
Net Income Available to Common
(48.64M) (23.70M) (21.99M) (10.21M)
EPS (Basic)
-1.5703 -0.6991 -0.5337 -0.2263
EPS (Basic) Growth
+31.34% +55.48% +23.66% +57.60%
Basic Shares Outstanding
30.98M 33.91M 41.20M 45.13M
EPS (Diluted)
-1.5703 -0.6991 -0.5337 -0.2263
EPS (Diluted) Growth
+31.34% +55.48% +23.66% +57.60%
Diluted Shares Outstanding
30.98M 33.91M 41.20M 45.13M
EBITDA
(35.92M) (7.89M) (6.65M) (361.24K)
EBITDA Growth
+32.78% +78.03% +15.67% +94.57%
EBITDA Margin
-30.17% -5.17% -3.13% -0.19%

Snapshot

Average Recommendation BUY Average Target Price 9.875
Number of Ratings 8 Current Quarters Estimate -0.147
FY Report Date 09 / 2026 Current Year's Estimate -0.519
Last Quarter’s Earnings -0.16 Median PE on CY Estimate N/A
Year Ago Earnings 0.25 Next Fiscal Year Estimate -0.053
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 7 7
Mean Estimate -0.15 -0.00 -0.52 -0.05
High Estimates -0.07 0.06 -0.44 0.26
Low Estimate -0.26 -0.08 -0.67 -0.26
Coefficient of Variance -41.47 -1,093.16 -16.79 -364.03

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Lifemd Inc in the News